J2KBio Co Ltd

J2KBio maintains a strong liquidity position with a current ratio of 7.09, indicating that it holds significantly more current assets than current liabilities. The company's liquidity_fpt metric shows a net cash position of -113,485,836 KRW, which is negative after subtracting total debt, suggesting that while the company is not highly leveraged, it may have limited cash reserves to cover short-term obligations. Profitability metrics show a return on equity (ROE) of 7.91% and a return on assets (ROA) of 7.02%, both of which are above the industry median for pharmaceuticals. This suggests that J2KBio is generating returns that are competitive with its peers, though not significantly outperforming them. The company's operating margin is 8.80%, which is in line with the industry average. The company's revenue is primarily derived from the production and sale of cosmetic materials, with a significant portion attributed to domestic operations in South Korea. There is no indication of material geographic diversification in the latest financial data, and the company does not report revenue by segment in the provided data. Looking ahead, J2KBio is projected to experience a modest growth trajectory, with revenue expected to increase by 3.2% in the current fiscal year and 4.1% in the following year. This growth is supported by a stable operating cash flow of 2,024,001,620 KRW and a free cash flow of 1,884,906,890 KRW, which provides the company with flexibility for reinvestment or shareholder returns. The company's risk profile is characterized by a low dilution potential, with no significant dilution sources identified in the latest filings. The risk assessment indicates a medium liquidity risk, primarily due to the negative net cash position after subtracting total debt. However, the company's debt-to-equity ratio of 0.03 suggests that it is not heavily reliant on debt financing, which reduces financial risk. Recent events include the filing of the latest financial statements, which show a consistent revenue trend and stable profitability. There are no material events or earnings call transcripts indicating significant changes in the company's strategic direction or operational performance.